Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

Carvedilol therapy is associated with a sustained decline in BNP and NANP levels. Serial BNP levels can provide some guidance regarding probability of LVEF improvement, but the relationship is not strong enough for BNP levels to supplant measurement of LVEF.